(Reuters) - ZURICH, June 21 - Swiss drugmaker Novartis
has received final U.S. approval for its high blood
pressure medicine Exforge.
Novartis said on Thursday that the U.S. Food and Drug
Administration had given the green light to Exforge, which
combines the two most commonly prescribed hypertension medicines
in one tablet, and that it would be available soon.
Read more at Reuters.com Government Filings News
has received final U.S. approval for its high blood
pressure medicine Exforge.
Novartis said on Thursday that the U.S. Food and Drug
Administration had given the green light to Exforge, which
combines the two most commonly prescribed hypertension medicines
in one tablet, and that it would be available soon.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment